Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,940 | 539 | 99.0% |
| Entertainment | $52.89 | 1 | 0.5% |
| Education | $48.32 | 8 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,619 | 98 | $0 (2022) |
| PFIZER INC. | $1,400 | 100 | $0 (2020) |
| GlaxoSmithKline, LLC. | $926.02 | 48 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $818.70 | 55 | $0 (2021) |
| Amgen Inc. | $642.66 | 23 | $0 (2020) |
| Novo Nordisk Inc | $622.93 | 38 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $579.31 | 19 | $0 (2021) |
| Amarin Pharma Inc. | $360.32 | 31 | $0 (2021) |
| Lilly USA, LLC | $357.71 | 24 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $320.67 | 33 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $521.28 | 5 | AstraZeneca Pharmaceuticals LP ($331.50) |
| 2021 | $839.78 | 27 | AstraZeneca Pharmaceuticals LP ($331.94) |
| 2020 | $596.95 | 35 | PFIZER INC. ($165.89) |
| 2019 | $2,310 | 134 | PFIZER INC. ($507.03) |
| 2018 | $2,998 | 156 | AstraZeneca Pharmaceuticals LP ($762.75) |
| 2017 | $2,776 | 191 | AstraZeneca Pharmaceuticals LP ($584.79) |
All Payment Transactions
548 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/05/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $124.57 | General |
| Category: Central Nervous System | ||||||
| 08/24/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $82.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/26/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.56 | General |
| Category: Respiratory | ||||||
| 04/20/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $65.21 | General |
| Category: Central Nervous System | ||||||
| 02/22/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.57 | General |
| Category: Respiratory | ||||||
| 12/07/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $99.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/09/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $114.16 | General |
| Category: RESPIRATORY | ||||||
| 06/29/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: RESPIRATORY | ||||||
| 06/03/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: RESPIRATORY | ||||||
| 06/01/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/20/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Cardiovascular | ||||||
| 05/18/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: DIABETES | ||||||
| 05/13/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 04/29/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: Diabetes | ||||||
| 04/19/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: DIABETES | ||||||
| 04/05/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: RESPIRATORY | ||||||
| 03/26/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Respiratory | ||||||
| 03/24/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $120.36 | General |
| Category: RESPIRATORY | ||||||
| 03/23/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $109.60 | General |
| Category: Respiratory | ||||||
| 03/22/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: RESPIRATORY | ||||||
| 03/22/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: RESPIRATORY | ||||||
| 03/16/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/08/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 360 | 507 | $121,791 | $32,159 |
| 2022 | 7 | 514 | 833 | $166,989 | $60,372 |
| 2021 | 11 | 701 | 1,237 | $178,202 | $80,465 |
| 2020 | 16 | 1,308 | 2,096 | $201,618 | $111,659 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 43 | 43 | $14,362 | $12,053 | 83.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 151 | 282 | $78,678 | $11,096 | 14.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 67 | 67 | $13,065 | $4,931 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 72 | $13,536 | $2,816 | 20.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 43 | 43 | $2,150 | $1,262 | 58.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 164 | 427 | $113,155 | $31,157 | 27.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 127 | 127 | $23,495 | $15,899 | 67.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 78 | 79 | $8,421 | $5,408 | 64.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 50 | $8,950 | $2,936 | 32.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 19 | $6,783 | $2,357 | 34.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 76 | 78 | $3,588 | $2,181 | 60.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 53 | $2,597 | $432.37 | 16.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 188 | 586 | $118,375 | $48,675 | 41.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 115 | 211 | $25,481 | $9,896 | 38.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 113 | 114 | $9,918 | $7,440 | 75.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 34 | 43 | $8,337 | $4,865 | 58.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 36 | 36 | $4,320 | $4,320 | 100.0% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 15 | 15 | $2,876 | $1,859 | 64.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 111 | 112 | $5,152 | $1,813 | 35.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 36 | 36 | $720.00 | $641.16 | 89.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 20 | 46 | $1,874 | $480.04 | 25.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 20 | 21 | $715.00 | $339.15 | 47.4% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2021 | 13 | 17 | $434.00 | $137.25 | 31.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 178 | 541 | $81,150 | $39,513 | 48.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 184 | 535 | $61,560 | $25,880 | 42.0% |
About Dr. Ronald Kahn, M.D
Dr. Ronald Kahn, M.D is a Family Medicine healthcare provider based in Kettering, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1508843079.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Kahn, M.D has received a total of $10,041 in payments from pharmaceutical and medical device companies, with $521.28 received in 2022. These payments were reported across 548 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($9,940).
As a Medicare-enrolled provider, Kahn has provided services to 2,883 Medicare beneficiaries, totaling 4,673 services with total Medicare billing of $284,655. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Kettering, OH
- Active Since 12/27/2005
- Last Updated 06/15/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1508843079
Products in Payments
- FARXIGA (Drug) $1,375
- CHANTIX (Drug) $590.39
- BREZTRI (Drug) $469.92
- JARDIANCE (Drug) $446.63
- TRELEGY ELLIPTA (Drug) $437.85
- SYMBICORT (Drug) $365.82
- Vascepa (Drug) $360.32
- TOUJEO (Drug) $324.51
- Prolia (Biological) $312.78
- BYDUREON (Drug) $292.77
- EUCRISA (Drug) $282.14
- JANUVIA (Drug) $271.94
- Ozempic (Drug) $263.36
- ANORO (Drug) $236.77
- TRADJENTA (Drug) $202.78
- Tresiba (Drug) $198.14
- TRULICITY (Drug) $190.62
- AUSTEDO (Drug) $189.78
- XARELTO (Drug) $177.55
- Repatha (Biological) $171.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Kettering
Dr. Karl Rose, M.d, M.D
Family Medicine — Payments: $11,846
Annette Chavez, Md, MD
Family Medicine — Payments: $4,115
Mrs. Carol Ryan, Md, MD
Family Medicine — Payments: $3,210
Bradford Murphy, Do, DO
Family Medicine — Payments: $1,499
Dr. Bernard Rose, M.d, M.D
Family Medicine — Payments: $1,369
Dr. Arvin Nanda, Do, DO
Family Medicine — Payments: $1,048